Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Cancer Genetics|April 13, 2016
The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinomaAnna Biernacka, Peter D Tsongalis, Jason D Peterson, et al.Clinical Genetics|June 26, 2018
Evidence for HNRNPH1 being another gene for Bain type syndromic mental retardationJacek Pilch, Agnieszka A Koppolu, Anna Walczak, et al.Nature Structural & Molecular Biology|March 7, 2017
Genome-wide mapping of long-range contacts unveils clustering of DNA double-strand breaks at damaged active genesFrançois Aymard, Marion Aguirrebengoa, Emmanuelle Guillou, et al.Breast Cancer Research and Treatment|November 23, 2024
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltrationMargarite D Matossian, Christine Shiang, Deniz Nesli Dolcen, et al.Journal of Human Genetics|February 8, 2018
Novel de novo mutation affecting two adjacent aminoacids in the EED gene in a patient with Weaver syndromeRobert Smigiel, Anna Biernacka, Mateusz Biela, et al.Molecular Cell|October 2, 2018
Comprehensive Mapping of Histone Modifications at DNA Double-Strand Breaks Deciphers Repair Pathway Chromatin SignaturesThomas Clouaire, Vincent Rocher, Anahita Lashgari, et al.Nature Communications|August 10, 2020
Topoisomerase 1 prevents replication stress at R-loop-enriched transcription termination sitesAlexy Promonet, Ismaël Padioleau, Yaqun Liu, et al.Annals of Surgical Oncology|March 15, 2020
Correction to: Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving SurgeryBarbara L Smith, Conor R Lanahan, Michelle C Specht, et al.Annals of Surgical Oncology|January 4, 2020
Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving SurgeryBarbara L Smith, Conor R Lanahan, Michelle C Specht, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2012
Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasisOsamu Takahashi, Ritsuko Komaki, Paul D Smith, et al.Pageof 6